BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16820899)

  • 1. Expression of type I interferon receptor as a predictor of clinical response to interferon-alpha therapy of gastrointestinal cancers.
    Ota H; Nagano H; Doki Y; Sekimoto M; Kondo M; Wada H; Nakamura M; Noda T; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Dono K; Umeshita K; Nakamori S; Wakasa K; Sakon M; Monden M
    Oncol Rep; 2006 Aug; 16(2):249-55. PubMed ID: 16820899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules.
    Nagano H; Miyamoto A; Wada H; Ota H; Marubashi S; Takeda Y; Dono K; Umeshita K; Sakon M; Monden M
    Cancer; 2007 Dec; 110(11):2493-501. PubMed ID: 17941012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial expression of interferon alpha receptor 2 (IFNAR2) on CD34-positive cells and its down-regulation correlate with clinical response to interferon therapy in chronic myelogenous leukemia.
    Ito K; Tanaka H; Ito T; Sultana TA; Kyo T; Imanaka F; Ohmoto Y; Kimura A
    Eur J Haematol; 2004 Sep; 73(3):191-205. PubMed ID: 15287917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The up-regulation of type I interferon receptor gene plays a key role in hepatocellular carcinoma cells in the synergistic antiproliferative effect by 5-fluorouracil and interferon-alpha.
    Oie S; Ono M; Yano H; Maruyama Y; Terada T; Yamada Y; Ueno T; Kojiro M; Hirano K; Kuwano M
    Int J Oncol; 2006 Dec; 29(6):1469-78. PubMed ID: 17088986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stronger growth-inhibitory effect of interferon (IFN)-beta compared to IFN-alpha is mediated by IFN signaling pathway in hepatocellular carcinoma cells.
    Damdinsuren B; Nagano H; Wada H; Kondo M; Ota H; Nakamura M; Noda T; Natsag J; Yamamoto H; Doki Y; Umeshita K; Dono K; Nakamori S; Sakon M; Monden M
    Int J Oncol; 2007 Jan; 30(1):201-8. PubMed ID: 17143530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relative endogenous expression levels of the IFNAR2 isoforms influence the cytostatic and pro-apoptotic effect of IFNalpha on pleomorphic sarcoma cells.
    Gazziola C; Cordani N; Carta S; De Lorenzo E; Colombatti A; Perris R
    Int J Oncol; 2005 Jan; 26(1):129-40. PubMed ID: 15586233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of IFN-alpha/beta receptor in the PBMCs and liver of patients with hepatitis B and its clinical significance].
    Fan HB; Guo YB; Wang BJ; Zhu YF; Wu AH; Hou JL; Yang DL
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):979-81. PubMed ID: 18583243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type-I interferon receptor expression: its circadian rhythm and downregulation after interferon-alpha administration in peripheral blood cells from renal cancer patients.
    Shiba M; Nonomura N; Nakai Y; Nakayama M; Takayama H; Inoue H; Tsujimura A; Nishimura K; Okuyama A
    Int J Urol; 2009 Apr; 16(4):356-9. PubMed ID: 19302507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational and structural analysis of the binding interface between type I interferons and their receptor Ifnar2.
    Piehler J; Schreiber G
    J Mol Biol; 1999 Nov; 294(1):223-37. PubMed ID: 10556041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a soluble ternary complex formed between human interferon-beta-1a and its receptor chains.
    Arduini RM; Strauch KL; Runkel LA; Carlson MM; Hronowski X; Foley SF; Young CN; Cheng W; Hochman PS; Baker DP
    Protein Sci; 1999 Sep; 8(9):1867-77. PubMed ID: 10493588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free interferon-alpha/beta receptors in the circulation of patients with adenocarcinoma.
    Ambrus JL; Dembinski W; Ambrus JL; Sykes DE; Akhter S; Kulaylat MN; Islam A; Chadha KC
    Cancer; 2003 Dec; 98(12):2730-3. PubMed ID: 14669296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Type I IFN receptor].
    Hino K; Yamaguchi Y; Okita K
    Nihon Rinsho; 2001 Jul; 59(7):1351-5. PubMed ID: 11494550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional expression of human type I interferon receptors in the mouse liver.
    Tochizawa S; Muraguchi M; Ohmoto Y; Oga K; Mori T
    Biochem Biophys Res Commun; 2006 Jul; 346(1):61-6. PubMed ID: 16750512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon-alpha.
    Esuvaranathan K; Chiong E; Thamboo TP; Chan YH; Kamaraj R; Mahendran R; Teh M
    Cancer; 2007 Mar; 109(6):1097-105. PubMed ID: 17311305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-alpha and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression.
    Ota H; Nagano H; Sakon M; Eguchi H; Kondo M; Yamamoto T; Nakamura M; Damdinsuren B; Wada H; Marubashi S; Miyamoto A; Dono K; Umeshita K; Nakamori S; Wakasa K; Monden M
    Br J Cancer; 2005 Sep; 93(5):557-64. PubMed ID: 16106266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic resection followed by IFN-alpha and 5-FU for advanced hepatocellular carcinoma with tumor thrombus in the major portal branch.
    Nagano H; Sakon M; Eguchi H; Kondo M; Yamamoto T; Ota H; Nakamura M; Wada H; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Dono K; Umeshit K; Nakamori S; Monden M
    Hepatogastroenterology; 2007; 54(73):172-9. PubMed ID: 17419255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers.
    Lamken P; Lata S; Gavutis M; Piehler J
    J Mol Biol; 2004 Jul; 341(1):303-18. PubMed ID: 15312780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical detection of the type I interferon receptor in human fetal, adult, and neoplastic tissues.
    Navarro S; Colamonici OR; Llombart-Bosch A
    Mod Pathol; 1996 Feb; 9(2):150-6. PubMed ID: 8657722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A flow cytometric method for determination of the interferon receptor IFNAR2 subunit in peripheral blood leukocyte subsets.
    Tochizawa S; Akamatsu S; Sugiyama Y; Muraguchi M; Ohmoto Y; Ono Y; Ishikawa H; Tanigami A; Sumida T; Mori T
    J Pharmacol Toxicol Methods; 2004; 50(1):59-66. PubMed ID: 15233969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins.
    Wada H; Nagano H; Yamamoto H; Arai I; Ota H; Nakamura M; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Doki Y; Dono K; Nakamori S; Sakon M; Monden M
    Oncol Rep; 2007 Oct; 18(4):801-9. PubMed ID: 17786339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.